Lang James Paul

Director at Halo Technology Holdings, Inc. · on record since May 7, 2026
Director at OptimizeRx Corp · on record since Jun 10, 2026
Director at BIOVIE INC. · on record since Aug 15, 2018

Insider trading activity of Lang James Paul

Transactions on record: 60; since Apr 6, 2017

Open-market buys: 2; $2.5M

Open-market sells: 0

Companies traded: 3; last filing Jun 10, 2026

Figures computed from official regulatory filings — .

Companies where Lang James Paul has traded

OptimizeRx Corp35 tx · $2.5M · Jun 10, 2026
Halo Technology Holdings, Inc.4 tx · May 7, 2026
BIOVIE INC.21 tx · $1.6M · Jan 9, 2026

Track record of Lang James Paul

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lang James Paul

Co-insiders of Lang James Paul

Adams Jonathan MBIOVIE INC.
Ahlem Clarence N.BIOVIE INC.
Anderson Julie GBIOVIE INC.
Archambault BryanOptimizeRx Corp
Armour Alison A.Halo Technology Holdings, Inc.
AWM Investment Company, Inc.OptimizeRx Corp
Bailey JeffHalo Technology Holdings, Inc.
BAKER DOUGLAS POptimizeRx Corp
BERMAN RICHARD JBIOVIE INC.
Besch DougOptimizeRx Corp
Bienvenu Rodney AHalo Technology Holdings, Inc.
BIZZARI JEAN-PIERREHalo Technology Holdings, Inc.
Boehmer John AHalo Technology Holdings, Inc.
Brooks James MOptimizeRx Corp
Caudill CortneyHalo Technology Holdings, Inc.
Chappell Amy SuzonBIOVIE INC.
Chondros DimitriosHalo Technology Holdings, Inc.
Connaughton BernadetteHalo Technology Holdings, Inc.
Countouriotis AthenaHalo Technology Holdings, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OptimizeRx CorpListing on record	Jun 10, 2026	Award	34,517	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	May 7, 2026	Award	3,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	May 7, 2026	AwardD (derivative)	6,040	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 9, 2026	AwardD (derivative)	330,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 9, 2026	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	Jan 6, 2026	AwardD (derivative)	1,342	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	Jan 6, 2026	Award	889	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 12, 2025	Award	9,868	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Mar 19, 2025	Buy	321,408	7.60 USD	$2.4M	conv 69First in 12mo	SEC
BIOVIE INC.Listing on record	Jan 7, 2025	AwardD (derivative)	22,690	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 7, 2025	AwardD (derivative)	61,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	Exercise	10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	ExerciseD (derivative)	-10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	Award	13,286	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Dec 6, 2023	AwardD (derivative)	93,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	ExerciseD (derivative)	-4,637	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	Exercise	4,637	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	AwardD (derivative)	10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Apr 3, 2023	ExerciseD (derivative)	-657	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Apr 3, 2023	Exercise	657	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 18, 2023	Award	43,578	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jan 4, 2023	ExerciseD (derivative)	-409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jan 4, 2023	Exercise	409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Sep 30, 2022	ExerciseD (derivative)	-334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Sep 30, 2022	Exercise	334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
OptimizeRx CorpListing on record	Jun 10, 2026	Award	34,517	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	May 7, 2026	Award	3,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	May 7, 2026	AwardD (derivative)	6,040	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 9, 2026	AwardD (derivative)	330,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 9, 2026	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	Jan 6, 2026	AwardD (derivative)	1,342	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Halo Technology Holdings, Inc.Listing unverified	Jan 6, 2026	Award	889	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 12, 2025	Award	9,868	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Mar 19, 2025	Buy	321,408	7.60 USD	$2.4M	conv 69First in 12mo	SEC
BIOVIE INC.Listing on record	Jan 7, 2025	AwardD (derivative)	22,690	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 7, 2025	AwardD (derivative)	61,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	Exercise	10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	ExerciseD (derivative)	-10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jun 11, 2024	Award	13,286	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Dec 6, 2023	AwardD (derivative)	93,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	ExerciseD (derivative)	-4,637	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	Exercise	4,637	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Aug 18, 2023	AwardD (derivative)	10,061	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Apr 3, 2023	ExerciseD (derivative)	-657	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Apr 3, 2023	Exercise	657	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BIOVIE INC.Listing on record	Jan 18, 2023	Award	43,578	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jan 4, 2023	ExerciseD (derivative)	-409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Jan 4, 2023	Exercise	409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Sep 30, 2022	ExerciseD (derivative)	-334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
OptimizeRx CorpListing on record	Sep 30, 2022	Exercise	334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC